Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.35 CAD
Change Today -0.01 / -2.82%
Volume 21.8K
GEN On Other Exchanges
Symbol
Exchange
Toronto
OTC US
As of 2:01 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lawrence Cohen

Member of Colorectal Cancer Clinical Advisory Board, GeneNews Limited
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 5 different industries.

See Board Relationships
651,288,000

Background*

Mr. Lawrence Cohen has been Chief Executive Officer of Exalenz Bioscience Ltd since March 4, 2013. Previously, Mr. Cohen served as Chief Executive Officer of SenGenix, Inc. He served also as Director at SenGenix, Inc. Mr. Cohen served as the President of International Technidyne Corp. (ITC), a subsidiary of Thoratec Corporation from May 2001 to November 4, 2010. Prior to joining ITC in May 2001, Mr. Cohen served as Chief Executive Officer of HemoSense, Inc. from August ...

Read Full Background

Corporate Headquarters*

445 Apple Creek Boulevard
Markham, Ontario L3R 9X7

Canada

Phone: 905-209-2030
Fax: 905-209-2031

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
University of Toronto
Doctorate
McMaster University

Other Affiliations*

Annual Compensation*

Salary1,102,000
Total Annual Compensation1,102,000

Stock Options*

Restricted Stock Awards186,000

Total Compensation*

Total Annual Cash Compensation1,102,000
Total Short Term Compensation1,102,000
Other Long Term Compensation186,000
Total Calculated Compensation1,288,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEN:CN C$0.35 CAD -0.01

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENENEWS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.